{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:20:55Z","timestamp":1774452055601,"version":"3.50.1"},"reference-count":89,"publisher":"Elsevier","isbn-type":[{"value":"9780128152058","type":"print"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/bs.acc.2018.02.006","type":"book-chapter","created":{"date-parts":[[2018,3,6]],"date-time":"2018-03-06T08:50:20Z","timestamp":1520326220000},"page":"71-89","source":"Crossref","is-referenced-by-count":19,"title":["Obesity, Thrombotic Risk, and Inflammation in Cancer"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.acc.2018.02.006_bb0010","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.med.080708.082713","article-title":"Biological mechanisms linking obesity and cancer risk: new perspectives","volume":"61","author":"Roberts","year":"2010","journal-title":"Annu. Rev. Med."},{"issue":"3","key":"10.1016\/bs.acc.2018.02.006_bb0015","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/micc.12270","article-title":"Obesity and cancer: an angiogenic and inflammatory link","volume":"23","author":"Fukumura","year":"2016","journal-title":"Microcirculation"},{"key":"10.1016\/bs.acc.2018.02.006_bb0020","doi-asserted-by":"crossref","first-page":"291546","DOI":"10.1155\/2013\/291546","article-title":"Obesity as a major risk factor for cancer","volume":"2013","author":"De Pergola","year":"2013","journal-title":"J. Obes."},{"issue":"7","key":"10.1016\/bs.acc.2018.02.006_bb0025","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/bjc.2016.37","article-title":"From obesity to diabetes and cancer: epidemiological links and role of therapies","volume":"114","author":"Garcia-Jimenez","year":"2016","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0030","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13813450801954303","article-title":"Obesity and cancer: pathophysiological and biological mechanisms","volume":"114","author":"Renehan","year":"2008","journal-title":"Arch. Physiol. Biochem."},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1055\/s-2005-863812","article-title":"Thrombophilia in cancer","volume":"31","author":"Falanga","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"issue":"4","key":"10.1016\/bs.acc.2018.02.006_bb0040","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/archinte.166.4.458","article-title":"Incidence of venous thromboembolism and its effect on survival among patients with common cancers","volume":"166","author":"Chew","year":"2006","journal-title":"Arch. Intern. Med."},{"issue":"6","key":"10.1016\/bs.acc.2018.02.006_bb0045","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/10428190600560991","article-title":"Venous thromboembolism in patients with diffuse large B-cell lymphoma","volume":"47","author":"Komrokji","year":"2006","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0050","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/00005792-199909000-00001","article-title":"Rates of initial and recurrent thromboembolic disease among patients with malignancy versus those without malignancy. Risk analysis using Medicare claims data","volume":"78","author":"Levitan","year":"1999","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"10.1016\/bs.acc.2018.02.006_bb0055","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1111\/jth.13483","article-title":"Factors influencing adherence to clinical guidelines in the management of cancer-associated thrombosis","volume":"14","author":"Mahe","year":"2016","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/bs.acc.2018.02.006_bb0060","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1055\/s-2003-40966","article-title":"Pathogenesis of increased risk of thrombosis in cancer","volume":"29","author":"Kwaan","year":"2003","journal-title":"Semin. Thromb. Hemost."},{"issue":"9465","key":"10.1016\/bs.acc.2018.02.006_bb0065","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(05)71880-8","article-title":"Deep vein thrombosis","volume":"365","author":"Kyrle","year":"2005","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1055\/s-2004-822969","article-title":"Tissue factor and fibrin in tumor angiogenesis","volume":"30","author":"Fernandez","year":"2004","journal-title":"Semin. Thromb. Hemost."},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0075","first-page":"190","article-title":"Pathogenic mechanisms of thrombosis in neoplasia: therapeutic implications","volume":"122","author":"Lopez-Pedrera","year":"2004","journal-title":"Med. Clin. (Barc)"},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1182\/blood-2004-06-2225","article-title":"Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall","volume":"105","author":"Day","year":"2005","journal-title":"Blood"},{"issue":"7","key":"10.1016\/bs.acc.2018.02.006_bb0085","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2004-09-3567","article-title":"Tissue factor activity in whole blood","volume":"105","author":"Butenas","year":"2005","journal-title":"Blood"},{"issue":"2","key":"10.1016\/bs.acc.2018.02.006_bb0090","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1046\/j.1365-2141.2001.03095.x","article-title":"Thrombogenic role of cells undergoing apoptosis","volume":"115","author":"Wang","year":"2001","journal-title":"Br. J. Haematol."},{"issue":"3","key":"10.1016\/bs.acc.2018.02.006_bb0095","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2796.2004.01444.x","article-title":"Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases","volume":"257","author":"Dahlback","year":"2005","journal-title":"J. Intern. Med."},{"issue":"6","key":"10.1016\/bs.acc.2018.02.006_bb0100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1161\/01.ATV.0000130465.23430.74","article-title":"Role of tissue factor in hemostasis, thrombosis, and vascular development","volume":"24","author":"Mackman","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"2","key":"10.1016\/bs.acc.2018.02.006_bb0105","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s12016-010-8240-0","article-title":"The clinical significance of coagulation and the inflammatory response in autoimmunity","volume":"42","author":"Rubio-Jurado","year":"2012","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/bs.acc.2018.02.006_bb0110","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1002\/bjs.7100","article-title":"Association of visceral adiposity with oesophageal and junctional adenocarcinomas","volume":"97","author":"Beddy","year":"2010","journal-title":"Br. J. Surg."},{"issue":"17","key":"10.1016\/bs.acc.2018.02.006_bb0115","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1200\/JCO.2014.59.4358","article-title":"Immune checkpoint blockade in cancer therapy","volume":"33","author":"Postow","year":"2015","journal-title":"J. Clin. Oncol."},{"issue":"9945","key":"10.1016\/bs.acc.2018.02.006_bb0120","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5.24 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"issue":"17","key":"10.1016\/bs.acc.2018.02.006_bb0125","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"9612","key":"10.1016\/bs.acc.2018.02.006_bb0130","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/bs.acc.2018.02.006_bb0135","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/S0029665115004176","article-title":"Obesity-associated cancer: an immunological perspective","volume":"75","author":"Conroy","year":"2016","journal-title":"Proc. Nutr. Soc."},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2010.02.001","article-title":"Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes","volume":"8","author":"Nam","year":"2010","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"12","key":"10.1016\/bs.acc.2018.02.006_bb0145","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nrc2536","article-title":"Insulin and insulin-like growth factor signalling in neoplasia","volume":"8","author":"Pollak","year":"2008","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0150","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1210\/en.2012-2165","article-title":"Minireview: nuclear insulin and insulin-like growth factor-1 receptors: a novel paradigm in signal transduction","volume":"154","author":"Sarfstein","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/bs.acc.2018.02.006_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","article-title":"Inflammatory mechanisms in obesity","volume":"29","author":"Gregor","year":"2011","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/bs.acc.2018.02.006_bb0160","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1749-6632.2011.06096.x","article-title":"The growing challenge of obesity and cancer: an inflammatory issue","volume":"1229","author":"Harvey","year":"2011","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2018.02.006_bb0165","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1749-6632.2012.06737.x","article-title":"Obesity, metabolic dysregulation, and cancer: a growing concern and an inflammatory (and microenvironmental) issue","volume":"1271","author":"Hursting","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/bs.acc.2018.02.006_bb0170","doi-asserted-by":"crossref","first-page":"554","DOI":"10.3332\/ecancer.2015.554","article-title":"Why does obesity promote cancer? Epidemiology, biology, and open questions","volume":"9","author":"Mazzarella","year":"2015","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0175","doi-asserted-by":"crossref","first-page":"633","DOI":"10.3892\/ol.2015.3965","article-title":"Globular adiponectin enhances invasion in human breast cancer cells","volume":"11","author":"Falk Libby","year":"2016","journal-title":"Oncol. Lett."},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5662\/wjm.v6.i1.43","article-title":"Oncogenic role of leptin and Notch interleukin-1 leptin crosstalk outcome in cancer","volume":"6","author":"Lipsey","year":"2016","journal-title":"World J. Methodol."},{"issue":"24","key":"10.1016\/bs.acc.2018.02.006_bb0185","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.1182\/blood-2010-02-270116","article-title":"Prediction of venous thromboembolism in cancer patients","volume":"116","author":"Ay","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0190","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.thromres.2005.10.015","article-title":"Chemotherapy-induced thrombosis","volume":"118","author":"Haddad","year":"2006","journal-title":"Thromb. Res."},{"issue":"17","key":"10.1016\/bs.acc.2018.02.006_bb0195","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1200\/JCO.2013.49.1118","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update","volume":"31","author":"Lyman","year":"2013","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/bs.acc.2018.02.006_bb0200","first-page":"313","article-title":"Thrombophilia, autoimmunity, and perioperative thromboprophylaxis","volume":"75","author":"Rubio-Jurado","year":"2007","journal-title":"Cir. Cir."},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0205","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/s-2005-863803","article-title":"Genetic testing for thrombophilia mutations","volume":"31","author":"Hertzberg","year":"2005","journal-title":"Semin. Thromb. Hemost."},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1182\/blood.V98.1.21","article-title":"Genetic hypercoagulability: prevention suggests testing family members","volume":"98","author":"Mannucci","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2141.2003.03976.x","article-title":"Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial","volume":"120","author":"Cushman","year":"2003","journal-title":"Br. J. Haematol."},{"issue":"6","key":"10.1016\/bs.acc.2018.02.006_bb0220","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.2005.03.5956","article-title":"Anthracyclines cause endothelial injury in pediatric cancer patients: a pilot study","volume":"24","author":"Chow","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"13","key":"10.1016\/bs.acc.2018.02.006_bb0225","doi-asserted-by":"crossref","first-page":"2878","DOI":"10.1182\/blood-2008-06-165845","article-title":"D-dimer antigen: current concepts and future prospects","volume":"113","author":"Adam","year":"2009","journal-title":"Blood"},{"issue":"13","key":"10.1016\/bs.acc.2018.02.006_bb0230","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMoa023153","article-title":"Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis","volume":"349","author":"Wells","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/bs.acc.2018.02.006_bb0235","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1056\/NEJMp030084","article-title":"D-dimer in venous thromboembolism","volume":"349","author":"Bockenstedt","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"10.1016\/bs.acc.2018.02.006_bb0240","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/archinte.162.7.747","article-title":"Plasma D-dimers in the diagnosis of venous thromboembolism","volume":"162","author":"Kelly","year":"2002","journal-title":"Arch. Intern. Med."},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0245","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.transci.2007.12.005","article-title":"Thrombin generation, fibrin clot formation and hemostasis","volume":"38","author":"Wolberg","year":"2008","journal-title":"Transfus. Apher. Sci."},{"issue":"9","key":"10.1016\/bs.acc.2018.02.006_bb0250","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1157\/13078652","article-title":"Usefulness of fast ELISA determination of D-dimer levels for diagnosing pulmonary embolism in an emergency room","volume":"41","author":"Friera-Reyes","year":"2005","journal-title":"Arch. Bronconeumol."},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0255","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/jth.12070","article-title":"International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer","volume":"11","author":"Farge","year":"2013","journal-title":"J. Thromb. Haemost."},{"issue":"11","key":"10.1016\/bs.acc.2018.02.006_bb0260","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.6004\/jnccn.2013.0163","article-title":"Venous thromboembolic disease","volume":"11","author":"Streiff","year":"2013","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"12","key":"10.1016\/bs.acc.2018.02.006_bb0265","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1172\/JCI27196","article-title":"Platelets in inflammation and atherogenesis","volume":"115","author":"Gawaz","year":"2005","journal-title":"J. Clin. Invest."},{"issue":"7","key":"10.1016\/bs.acc.2018.02.006_bb0270","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1182\/blood-2005-04-1530","article-title":"Activated platelets induce Weibel-Palade-body secretion and leukocyte rolling in vivo: role of P-selectin","volume":"106","author":"Dole","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0275","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.2010.29.7614","article-title":"Effect of obesity on prognosis after early-stage breast cancer","volume":"29","author":"Ewertz","year":"2011","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/bs.acc.2018.02.006_bb0280","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3390\/cancers7040883","article-title":"The interactions of obesity, inflammation and insulin resistance in breast cancer","volume":"7","author":"Rose","year":"2015","journal-title":"Cancers (Basel)"},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0285","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1210\/er.2007-0001","article-title":"The complex role of estrogens in inflammation","volume":"28","author":"Straub","year":"2007","journal-title":"Endocr. Rev."},{"key":"10.1016\/bs.acc.2018.02.006_bb0290","doi-asserted-by":"crossref","first-page":"615917","DOI":"10.1155\/2014\/615917","article-title":"Estrogen signaling in metabolic inflammation","volume":"2014","author":"Monteiro","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/bs.acc.2018.02.006_bb0295","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-994917","article-title":"Thrombophilic state in breast cancer","volume":"25","author":"Schmitt","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"issue":"8","key":"10.1016\/bs.acc.2018.02.006_bb0300","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1002\/cncr.11702","article-title":"Coagulopathic complications in breast cancer","volume":"98","author":"Caine","year":"2003","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/bs.acc.2018.02.006_bb0305","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.ctrv.2011.06.009","article-title":"Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review","volume":"38","author":"Iqbal","year":"2012","journal-title":"Cancer Treat. Rev."},{"issue":"6","key":"10.1016\/bs.acc.2018.02.006_bb0310","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ijsu.2012.05.001","article-title":"Stopping tamoxifen peri-operatively for VTE risk reduction: a proposed management algorithm","volume":"10","author":"Hussain","year":"2012","journal-title":"Int. J. Surg."},{"issue":"2","key":"10.1016\/bs.acc.2018.02.006_bb0315","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J. Clin."},{"issue":"2","key":"10.1016\/bs.acc.2018.02.006_bb0320","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.lungcan.2011.04.009","article-title":"Tumor-associated macrophages provide a suitable microenvironment for non-small lung cancer invasion and progression","volume":"74","author":"Wang","year":"2011","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0325","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1093\/annonc\/mds647","article-title":"Rationale for targeting the immune system through checkpoint molecule blockade in the treatment of non-small-cell lung cancer","volume":"24","author":"Zielinski","year":"2013","journal-title":"Ann. Oncol."},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1097\/MCP.0b013e328209413c","article-title":"Risk of venous thromboembolism in lung cancer","volume":"13","author":"Tesselaar","year":"2007","journal-title":"Curr. Opin. Pulm. Med."},{"issue":"9","key":"10.1016\/bs.acc.2018.02.006_bb0335","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.5858\/arpa.2012-0490-RA","article-title":"Assessing the risk and prognosis of thrombotic complications in cancer patients","volume":"137","author":"Kyriazi","year":"2013","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"4","key":"10.1016\/bs.acc.2018.02.006_bb0340","doi-asserted-by":"crossref","first-page":"670","DOI":"10.4143\/crt.2014.045","article-title":"Cisplatin-based chemotherapy is a strong risk factor for thromboembolic events in small-cell lung cancer","volume":"47","author":"Lee","year":"2015","journal-title":"Cancer Res. Treat."},{"issue":"3","key":"10.1016\/bs.acc.2018.02.006_bb0345","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.lungcan.2014.10.003","article-title":"Early venous thromboembolic events are associated with worse prognosis in patients with lung cancer","volume":"86","author":"Kourelis","year":"2014","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0350","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3945\/ajcn.113.066530","article-title":"Weight change later in life and colon and rectal cancer risk in participants in the EPIC-PANACEA study","volume":"99","author":"Steins Bisschop","year":"2014","journal-title":"Am. J. Clin. Nutr."},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0355","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00595-013-0606-5","article-title":"Colorectal cancer and hypercoagulability","volume":"44","author":"Kawai","year":"2014","journal-title":"Surg. Today"},{"issue":"3","key":"10.1016\/bs.acc.2018.02.006_bb0360","first-page":"22","article-title":"Von Willebrand factor as an intermediate between hemostasis and angiogenesis of tumor origin","volume":"47","author":"Gil-Bazo","year":"2003","journal-title":"Rev. Med. Univ. Navarra"},{"issue":"14","key":"10.1016\/bs.acc.2018.02.006_bb0365","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.3748\/wjg.v11.i14.2166","article-title":"Plasma von Willebrand factor level as a prognostic indicator of patients with metastatic colorectal carcinoma","volume":"11","author":"Wang","year":"2005","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0370","first-page":"745","article-title":"Coagulation markers predict survival in cancer patients","volume":"88","author":"Beer","year":"2002","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0375","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/jth.12533","article-title":"Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from England","volume":"12","author":"Walker","year":"2014","journal-title":"J. Thromb. Haemost."},{"issue":"6086","key":"10.1016\/bs.acc.2018.02.006_bb0380","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1126\/science.1224203","article-title":"The application of ecological theory toward an understanding of the human microbiome","volume":"336","author":"Costello","year":"2012","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0385","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1600-065X.2012.01151.x","article-title":"The inflammation highway: metabolism accelerates inflammatory traffic in obesity","volume":"249","author":"Johnson","year":"2012","journal-title":"Immunol. Rev."},{"issue":"8","key":"10.1016\/bs.acc.2018.02.006_bb0390","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1038\/nm0809-846","article-title":"T-ing up inflammation in fat","volume":"15","author":"Lumeng","year":"2009","journal-title":"Nat. Med."},{"issue":"6086","key":"10.1016\/bs.acc.2018.02.006_bb0395","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host-gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"issue":"6086","key":"10.1016\/bs.acc.2018.02.006_bb0400","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1126\/science.1223490","article-title":"Interactions between the microbiota and the immune system","volume":"336","author":"Hooper","year":"2012","journal-title":"Science"},{"issue":"6161","key":"10.1016\/bs.acc.2018.02.006_bb0405","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1126\/science.1240527","article-title":"Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment","volume":"342","author":"Iida","year":"2013","journal-title":"Science"},{"issue":"8","key":"10.1016\/bs.acc.2018.02.006_bb0410","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrd1157","article-title":"Opinion: understanding \u2018global' systems biology: metabonomics and the continuum of metabolism","volume":"2","author":"Nicholson","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0415","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/1574-6976.12075","article-title":"The first 1000 cultured species of the human gastrointestinal microbiota","volume":"38","author":"Rajilic-Stojanovic","year":"2014","journal-title":"FEMS Microbiol. Rev."},{"issue":"44","key":"10.1016\/bs.acc.2018.02.006_bb0420","doi-asserted-by":"crossref","first-page":"15718","DOI":"10.1073\/pnas.0407076101","article-title":"The gut microbiota as an environmental factor that regulates fat storage","volume":"101","author":"Backhed","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/bs.acc.2018.02.006_bb0425","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.coph.2015.09.013","article-title":"The microbiome and its pharmacological targets: therapeutic avenues in cardiometabolic diseases","volume":"25","author":"Neves","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0430","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13073-016-0303-2","article-title":"Impact of the gut microbiota on inflammation, obesity, and metabolic disease","volume":"8","author":"Boulange","year":"2016","journal-title":"Genome Med."},{"issue":"8","key":"10.1016\/bs.acc.2018.02.006_bb0435","first-page":"1095","article-title":"Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease","volume":"4","author":"Brown","year":"2012","journal-title":"Forum Nutr."},{"issue":"5","key":"10.1016\/bs.acc.2018.02.006_bb0440","doi-asserted-by":"crossref","first-page":"545","DOI":"10.2217\/17460875.3.5.545","article-title":"Macrophage infiltration into adipose tissue: initiation, propagation and remodeling","volume":"3","author":"Surmi","year":"2008","journal-title":"Future Lipidol."},{"issue":"12","key":"10.1016\/bs.acc.2018.02.006_bb0445","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/bs.acc.2018.02.006_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-159-1-201307020-00003","article-title":"Salicylate (salsalate) in patients with type 2 diabetes: a randomized trial","volume":"159","author":"Goldfine","year":"2013","journal-title":"Ann. Intern. Med."}],"container-title":["Advances in Clinical Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242318300064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0065242318300064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:35:14Z","timestamp":1758742514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0065242318300064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9780128152058"],"references-count":89,"URL":"https:\/\/doi.org\/10.1016\/bs.acc.2018.02.006","relation":{},"ISSN":["0065-2423"],"issn-type":[{"value":"0065-2423","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}